Monkeypox crisis: A national public health concern in Democratic Republic of the Congo
Lucien Baraka, Leonard Sironge(Université Officielle de Bukavu), Jones Onesime(Université libre des Pays des Grands Lacs), Hugues Cakwira(Green Circle), Styves Banga(Green Circle), Chrispin Biamba(University of Goma), Innocent Mufungizi(Green Circle), Alain Balume(Université Officielle de Bukavu), Gentil Rajabu(Faculty (United Kingdom)), Aymar Akilimali(Roslin Institute), Samson Hangi, Elie Kihanduka, Christian Tague, Mayar Moustafa Budair(Cairo University), Francois RHUGENDABANGA, Hardy Elembwe(University of Goma), Excellent Rugendabanga, Bonk Muhoza(Université Officielle de Bukavu)
Cited by 2
Related Papers
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
|Annals of Medicine and Surgery|2024|87
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
|Annals of Medicine and Surgery|2023|30
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat
|Tropical Medicine and Health|2022|29
Barriers Encountered Toward Pursuing a Neurosurgical Career: A Cross-Sectional Study Among Medical Students, Interns, and Junior Doctors in Africa
|World Neurosurgery|2022|26
The unmet need of organ transplantation in Africa
|International Journal of Surgery|2023|21